Log In
BCIQ
Print this Print this
 

ORB0001

  Manage Alerts
Collapse Summary General Information
Company Oribase Pharma
DescriptionUndisclosed kinase inhibitor
Molecular Target
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today